Related Experiment Video
Updated: Mar 2, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Chronic Kidney Disease and Atrial Fibrillation: A Contemporary Overview
Nitin Kulkarni1, Nilusha Gukathasan1, Samantha Sartori1
1Mount Sinai School of Medicine, New York, NY 10029.
Insights
Patients with chronic kidney disease (CKD) have a higher risk of atrial fibrillation (AF). Antithrombotic therapy benefits require further study, especially in advanced renal failure.
Area of Science:
- Nephrology
- Cardiology
- Clinical Medicine
Background:
- Chronic kidney disease (CKD) significantly increases cardiovascular risks, including myocardial infarction, heart failure, and stroke.
- Atrial fibrillation (AF), a common arrhythmia, elevates stroke and mortality risk, with higher prevalence and incidence observed in patients with renal impairment.
- Worsening renal function correlates with an increased risk of developing AF, suggesting a strong link between kidney health and cardiac rhythm.
Purpose of the Study:
- To review the association between CKD and AF, including potential underlying mechanisms.
- To evaluate the current understanding of antithrombotic therapy's safety and efficacy in CKD patients with AF.
- To identify knowledge gaps and the need for further research regarding anticoagulation in this population.
Main Methods:
- Literature review and synthesis of existing studies on CKD, AF, and antithrombotic therapy.
- Analysis of potential pathophysiological links between renal impairment and atrial fibrillation.
- Examination of data on the efficacy and safety of anticoagulation in CKD patients, considering varying degrees of renal function.
Main Results:
- AF is more prevalent and incident in CKD patients, with risk increasing as kidney function declines.
- Mechanisms linking CKD and AF may involve sympathetic overactivity, renin-angiotensin-aldosterone system activation, and cardiac remodeling.
- While vitamin K antagonists show promise in mild-to-moderate CKD, the risk-benefit of anticoagulation in advanced renal failure and dialysis remains unclear.
Conclusions:
- AF poses a significant risk for stroke and mortality in CKD patients, mirroring general population trends.
- The safety and efficacy of antithrombotic treatments in CKD patients with AF are not well-established, particularly in advanced stages.
- Prospective randomized trials are essential to determine the optimal antithrombotic strategy for reducing stroke risk in patients with comorbid AF and CKD.
Abstract:
Chronic kidney disease (CKD) is associated with substantial cardiovascular morbidity, including myocardial infarction, heart failure and stroke. Similar to CKD, atrial fibrillation (AF) is a prevalent arrhythmia that increases risk for both stroke and overall mortality. Recent studies demonstrate that both prevalence and incidence of AF is higher in patient with versus without renal impairment and risk for developing AF increases as renal function worsens. Potential mechanisms for the higher burden of AF in CKD patients include but are not limited to augmented sympathetic tone, activation of the renin-angiotensin-aldosterone system and myocardial remodeling. Similar to the general population, AF confers an increased risk for both stroke and overall mortality in the CKD population. The safety and efficacy of antithrombotic therapy across the spectrum of CKD remains unknown, however, as patients with advanced renal failure are frequently excluded from randomized trials. While treatment with vitamin K antagonists appears to reduce ischemic complications without significant bleeding harm in patients with mild to moderate CKD and AF, the risk benefit ratio of anticoagulation among thosewith advanced renal failure on dialysis requires further investigation. Prospective, randomized trials are war ranted to define the impact of antithrombotic therapy on reducing stroke risk in patients with both AF and CKD.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care

